The Asia Pacific Specialty Medical Chairs Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028).
Specialty medical chairs are pieces of medical equipment used in the treatment, assessment, and rehabilitation of patients. The specialty chairs improve the mobility, flexibility, and comfort of the chairs, allowing surgeons to approach patients in the needed position or angle throughout the treatment or operation procedure. Throughout the treatment, the patient is extremely comfortable in these chairs. Doctors can employ these chairs as they see fit in their own fields of medicine by guiding them as needed.
Over the projected period, the expanding geriatric population is expected to increase the demand for specialty medical chairs. Furthermore, the emergence of technologically improved and fully automated medical chairs is expected to provide attractive growth possibilities for the market.
In high-income Asia-Pacific countries and territories, the proportion of people aged 65 and up is expected to nearly double between 2020 and 2050, reaching 32.6 percent for females and 27.5 percent for males, while the proportion of people aged 80 and up is expected to triple between 2020 and 2050, reaching 13.3 percent for females and 9.7 percent for males. In lower-middle and low-income Asia-Pacific countries, the proportion of people aged 65 and 80 will be two-thirds and three-quarters of what it is now, with 14.1 percent for females and 11 percent for males (population aged 65 years) and 3.1 percent for females and 1.9 percent for males (population aged 80 years) respectively (population aged over 80 years).
After controlling for price disparities between countries, lower-middle and low-income Asia-Pacific countries spend just under USD 250 per person per year on health, compared to USD 689 and USD 3,712 in upper-middle-income and high-income Asia-Pacific countries, respectively. In 2017, this amounted to about 4% of gross domestic product (GDP) in middle- and low-income Asia-Pacific countries, against 7.2 percent in high-income Asia-Pacific countries. From 2010 to 2017, high-income countries reported a rise of 0.7 percentage points on average, more than double the 0.3 percentage point gain reported by upper-middle-income countries. Between 2010 and 2017, the percentage of GDP spent on health in lower-middle and low-income nations remained unchanged (at 4 percent of GDP).
The China market dominated the Asia Pacific Specialty Medical Chairs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $462.5 million by 2028. The Japan market is poised to grow at a CAGR of 9.2% during (2022 - 2028). Additionally, The India market would display a CAGR of 10.5% during (2022 - 2028).
Based on Product, the market is segmented into Rehabilitation (Geriatric, Bariatric, Pediatric, and Others), Treatment (Dental, Ophthalmic, ENT, and Others), and Examination (Dialysis, Blood Drawing, Mammography, Cardiac, and Birthing). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Specialty Medical Chairs Market is Projected to reach USD 6.3 Billion by 2028, at a CAGR of 8.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Dentsply Sirona, Inc., Danaher Corporation, Fresenius SE & Co. KGaA, A-dec, Inc., DentalEZ, Inc., ActiveAid, LLC, Midmark Corporation, Planmeca Oy, and Hill Laboratories Company.
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
